Analysen von Jack Scannell
| 09.10.17 | Roche Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 31.08.17 | AstraZeneca Neutral | UBS AG | |
| 01.08.17 | AstraZeneca Neutral | UBS AG | |
| 27.07.17 | Roche Neutral | UBS AG | |
| 27.07.17 | AstraZeneca Neutral | UBS AG | |
| 06.07.17 | Roche Neutral | UBS AG | |
| 27.06.17 | AstraZeneca Neutral | UBS AG | |
|
Werbung
|
|||
| 14.06.17 | Sanofi Neutral | UBS AG | |
| 28.04.17 | Sanofi Neutral | UBS AG | |
| 27.04.17 | AstraZeneca Neutral | UBS AG | |
| 27.04.17 | Roche buy | UBS AG | |
| 05.04.17 | AstraZeneca Neutral | UBS AG | |
| 20.02.17 | Roche buy | UBS AG | |
| 16.02.17 | Sanofi Neutral | UBS AG | |
| 02.02.17 | AstraZeneca buy | UBS AG | |
| 11.01.17 | AstraZeneca buy | UBS AG | |
| 22.12.16 | Roche buy | UBS AG | |
| 13.12.16 | Sanofi Neutral | UBS AG | |
| 08.12.16 | Roche buy | UBS AG | |
| 14.09.16 | Bayer Neutral | UBS AG | |
| 08.06.12 | Bayer outperform | Sanford C. Bernstein and Co., Inc. | |
| 29.05.12 | Bayer outperform | Sanford C. Bernstein and Co., Inc. | |
| 23.04.12 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 27.03.12 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 31.01.12 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 17.01.12 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 16.08.11 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 28.07.11 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 24.06.11 | Merck outperform | Sanford C. Bernstein and Co., Inc. | |
| 02.11.10 | Fresenius Medical Care (FMC) St. outperform | Sanford C. Bernstein and Co., Inc. | |
| 30.06.10 | Fresenius Medical Care (FMC) St. kaufen | Sanford C. Bernstein and Co., Inc. | |